AstraZeneca Earnings Preview

Published on Wednesday, 01 February 2012 10:20 Written by Gerard Lerod

New York, February 1st (TradersHuddle.com) - Shares of AstraZeneca PLC (NYSE:AZN) are trading higher by +1.00% ahead of its quarterly earnings release. AstraZeneca, the London, England based biopharmaceutical company is expected to release its quarterly results on January 2^nd.

Wall Street Analysts consensus calls for a profit of $1.61 a share on $8.59 billion revenue.

AstraZeneca estimates have a range of $0.18 a share. The high estimate calls for profit of $1.72 a share and the low estimate is calling for a profit of $1.54 a share, a year ago for the quarter the company reported $1.39 a share.

AstraZeneca PLC (NYSE:AZN), through its subsidiaries, researches, manufactures and sells pharmaceutical and medical products. The Group focuses its operations on seven therapeutic areas: Gastrointestinal, Oncology, Cardiovascular, Respiratory, Central Nervous System, Pain Control, Anaesthesia and Infection.

Other companies on the watch on this earnings event are GlaxoSmithKline plc NYSE:GSK and Novartis AG NYSE:NVS.